Regional Covid-19 Resources and On Reserve Stats by Region Below:
Black = New Cases, Green = Recovered, Red = Deaths, Blue – Hospitalized, Purple – ISC reported total –  Updated Daily

BC
14 458 158 8,632 8,804
AB
9 1,046 185 20,082 20,311
SK
0 495 129 16,186 16,343
MB
4 901 155 25,118 25,283
ON
81 365 80 21,111 21,459
QC
86 115 26 13,653 13,793
Atlantic
0 14 9 4,614 4,658
North60
10 326 56 19,406 19,499
 

Canada authorizes Pfizer COVID-19 booster for 16- and 17-year-olds – CBC

Previously, booster shots were only approved for adolescents aged 12 to 17 who are vulnerable to COVID-19

Jun 01, 2022

Canada on Wednesday authorized a single booster shot of Pfizer and partner BioNTech’s COVID-19 vaccine for 16- and 17-year-olds.

Regulator Health Canada had cleared an extra dose of the vaccine for people 18 and older in November last year. The booster is meant to be administered six months after the primary two-dose series.

The decision was based on data from two studies of the booster shot among individuals 16 and older. The agency said potential risks of inflammatory heart conditions, myocarditis or pericarditis, have been included in the shot’s label.

The cases have been reported after administration of the Pfizer-BioNTech and Moderna’s COVID-19 shot, especially among young men. Health Canada had authorized a primary series of Pfizer’s shot for those 16 and older in December 2020.

Read more: https://www.cbc.ca/news/health/pfizer-covid-19-booster-approved-adolescents-16-and-17-1.6473932

NationTalk Partners & Sponsors Learn More